Ignite Creation Date:
2024-05-06 @ 2:01 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04191499
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2019-12-02
Brief Title:
A Study Evaluating the Efficacy and Safety of Inavolisib Palbociclib Fulvestrant vs Placebo Palbociclib Fulvestrant in Patients With PIK3CA-Mutant Hormone Receptor-Positive Her2-Negative Locally Advanced or Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2030-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-02
First Submit QC Date:
December 6 2019
Study First Post Date:
2019-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-17
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL